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Abstract
SUR2A is an ‘atypical’ ABC protein that forms sarcolemmal ATP-sensitive K+ (KATP) channels by binding to inward rectifier Kir6.2. Manipulation
with SUR2A levels has been suggested to be a promising therapeutic strategy against ischaemic heart diseases and other diseases where
increased heart resistance to stress is beneficial. Some years ago, it has been reported that high-altitude residents have lower mortality rates
for ischaemic heart disease. The purpose of this study was to determine whether SUR2A is regulated by mild-to-severe hypoxic conditions
(15% oxygen; oxygen tension equivalent to 3000 m above sea level) and elucidate the underlying mechanism. Mice were exposed to either to
21% (control) or 15% concentration of oxygen for 24 hrs. Twenty-four hours long exposure to 15% oxygen decreased partial pressure of O2
(PO2), but did not affect blood CO2 (PCO2), haematocrit nor levels of ATP, lactate and NAD+/NADH in the heart. Cardiac SUR2A levels were sig-
nificantly increased while Kir6.2 levels were not affected. Hypoxia did not induce phosphorylation of extracellular signal-regulated kinases
(ERK1/2) or protein kinase B (Akt), but triggered phosphorylation of AMP activated protein kinase (AMPK). AICAR, an activator of AMPK,
increased the level of SUR2A in H9c2 cells. We conclude that oxygen increases SUR2A level by activating AMPK. This is the first account of
AMPK-mediated regulation of SUR2A.
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Introduction
ATP-sensitive K+ (KATP) channels link intracellular metabolic condi-
tions with cellular membrane excitability, and they play a significant
role in regulating resistance to stress in different cell types [1–3]. The
sulfonylurea receptor 2A (SUR2A) is an ‘atypical’ ABC transporter
that, although possessing a structure of an ABC protein, it does not
mediate transport, but binds to the inward rectifier Kir6.2 to form sar-
colemmal KATP channels [4]. Recent studies showed the involvement
of SUR2A in regulation of myocardial resistance to metabolic and
oxidative stress [5–9] and to cardiac ageing [10, 11]. It has been
shown that increased level of SUR2A (i) protects myocardium against
ischaemia-reperfusion and other types of oxidative stress [5–9],
(ii) increases physical endurance [7], (iii) counteracts ageing-induced
increase in myocardial susceptibility to metabolic stress and decrease
in physical endurance [10] and (iv) reprogrammes embryonic car-
diomyocytes towards less differentiated stem-like cells [12].
Manipulation of SUR2A levels has been suggested to be a promis-
ing therapeutic strategy against ischaemic heart diseases and other
diseases where increased heart resistance to stress is beneficial [13–15].
Some years ago, it has been reported that high-altitude residents have
lower mortality rates due to ischaemic heart disease [15–18]. In
agreement with these early studies were later findings that exposure
to moderate hypoxia confers cardioprotection to rats [19, 20]. Under
in vitro conditions, it has been shown that SUR2A levels are more
sensitive to changes in oxygen tension than other proteins [21].
Recent in vivo studies demonstrated that exposure to subhypoxia
(20% oxygen; equivalent to 350 m above sea level), mild hypoxia
(18% oxygen; equivalent to 1200 m above sea level) or severe
hypoxia (13% oxygen; equivalent to 3600 m above sea level)
increases level of SUR2A and myocardial resistance to ischaemia-
reperfusion [8, 9, 22]. It has been shown that different oxygen ten-
sions activate different signalling cascades that have up-regulation of
SUR2A as common mechanism. Specifically, 20% oxygen activates
ERK1/2, 18% oxygen activates PI3K/Akt and 13% oxygen does not
activate any of tested kinases [8, 9, 22]. About 15% oxygen corre-
sponds to oxygen tension found at ~3000 m above sea level. It is yet
unknown whether this level of hypoxia would regulate SUR2A and
what the signalling cascade would be. Therefore, in this study we
have tested in vivo the impact of 24 hrs exposure to 15% oxygen on
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various biochemical and molecular parameters in experimental mice.
Not only that we have found that this concentration of oxygen
increased level of SUR2A but that this is due to the activation of
AMPK independently from ERK1/2 and PI3K/Akt.
Materials and methods
Mice and in vivo exposure to hypoxia
C57BL/6J male mice (6–8 weeks old) were exposed to either ambient
oxygen (detected to be 21%) or 15% oxygen (normobaric hypoxia)
using integral Animal Hypoxia Chamber System; oxygen levels were
controlled by ProOx Model 110 version 2.2 (Biospherix, Lacona, NY,
USA). Mice, in groups of 5 (comment requiring response), were
placed in a plexiglass chamber for 24 hrs in either 21% or 15% oxy-
gen, under continuous monitoring of oxygen level. Twenty-four hours
was the time of exposure as we have shown previously that within
this time frame, subhypoxia and different degrees of in vitro and
in vivo hypoxia regulate the level of SUR2A [8, 9, 21, 22]. Addition-
ally, other agents regulating SUR2A expression also act within 24 hrs
[23, 24]. All manipulation with animals including hearts harvesting
were performed inside the chamber. For heart harvesting, mice were
killed using a schedule 1 procedure of cervical dislocation. The experi-
ments have been carried out under the authority of Project Licence
70/7796.
H9c2 cells
In vitro experiments were performed on rat embryonic heart-derived
H9c2 cells (ECACC, Salisbury, UK). Cells were cultured in DMEM med-
ium containing 2 mM glutamine and 10% FCS at 37°C and 5% CO2. In
particular experiments, AICAR (1 mM in DMSO) was added into the cul-
ture media and DMSO-containing samples were considered as control
(1.3% was final DMSO concentration). The cultures were then left for a
24-hrs incubation period before experimentation.
Blood gas and haematocrit analysis
Blood gas (PO2 and PCO2) and haematocrit (HCT) were measured in
blood (500–700 ll) taken directly from the heart of experimental ani-
mals using pre-heparinized (1000 IU/ml) syringes and Rapidlab 348EX
blood Gas System (Siemens, Frimley, UK).
Western blotting
For Western blotting, hearts/H9c2 cells were harvested and snap-frozen
and homogenized in lysis buffer (50 mM Tris–HCl, pH 7.5; 1 mM EDTA;
1 mM EGTA; 1% (w/v) Triton X-100; 0.1% (v/v)-mercaptoethanol;
1 mM sodium orthovanadate; 50 mM sodium fluoride; 5 mM sodium
pyrophosphate; 1 lM microcystin-LR; and one tablet of ‘complete’ pro-
teinase inhibitor per 50 ml of buffer). Specifically, a 10-fold mass
excess of ice-cold lysis buffer was added to the powdered tissue/cells,
briefly vortexed and then centrifuged at 4°C for 10 min. at 13,000 9g
to remove insoluble material. The supernatant was snap-frozen in ali-
quots in liquid nitrogen and stored at 80°C. Protein concentration was
determined by the Bradford assay. From each sample, 20 lg of protein
was subjected to SDS/PAGE and transferred to nitrocellulose mem-
branes. For all blots, the nitrocellulose membranes were incubated at
4°C for 16 hrs using antibodies against SUR2A, Kir6.2 (both from Santa
Cruz Biotechnology, Heidelberg, Germany), Akt, AMPK, ERK1/2, phos-
pho-Akt antibodies (Thr308 and Ser473), phosphor-AMPK and phos-
pho-ERK1/2 (all from Millipore, Watford, UK). All antibodies were
applied in 1:1000 dilution. The blots were incubated in 50 mM Tris/HCl,
pH 7.5; 0.15 M NaCl; and 0.2% (v/v) Tween containing 5% (by mass)
skimmed milk. Detection of total or phosphorylated protein was per-
formed using horse radish peroxidase-conjugated secondary antibodies
(Pierce, Rockford, IL, USA) and enhanced chemiluminescence reagent
(Upstate, Dundee, UK). The band intensities were analysed using QUAN-
TISCAN software (Biosoft, Cambridge, UK). All blots have been per-
formed, at least, in triplicates.
Measurement of ATP in the heart
ATP concentration in heart tissue was measured using luciferase-based
ATP determination kit (Invitrogen, Paisley, UK) according to the manu-
facturer instructions. Luminescence was measured at 560 nm using
microplate reader/multidetection reader (SpectraMax M2; Molecular
Devices, Wokingham, UK).
Measurement of NAD/NADH in the heart
NAD/NADH was measured in heart tissue using NAD/NADH kit (Abcam,
Cambridge, UK) according to the manufacturer’s instruction. Absor-
bance was measured at 450 nm using microplate reader/multidetection
reader (SpectraMax M2; Molecular Devices). Total NAD (NADt) and
NADH were estimated directly while the value of NAD+ was estimated
by subtracting NADH from NADt.
Measurement of lactate in the heart
Lactate was measured in heart tissue lysates using ADVIA Chemistry
Lactate Enzymatic Assay and ADVIA Chemistry System 1200 (Sie-
mens). Lactate is oxidized by lactate oxidase to pyruvate and hydro-
gen peroxide, and it was measured by the formation of dye from
hydrogen peroxide and a chromogen in the presence of a peroxidase
according to manufacturer instructions. Absorbance was measured at
545/694 nm.
Statistical analysis
Data are presented as mean  S.E.M, with n representing the number
of analysed mice or independent experiments when H9c2 cells were
used. Mean values for all measurements were compared by Student’s
t-test or Mann–Whitney rank sum test where appropriate using SigmaS-
tat program (Jandel Scientific, Chicago, IL, USA). P < 0.05 was consid-
ered statistically significant.
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Results
24-hrs-long exposure to 15% oxygen up-
regulates SUR2A in the heart
Mice were exposed to either atmospheric oxygen that was measured
to be 21% (Dundee is situated at 74 m above the sea level) or to
mild-to-severe hypoxic conditions (15% oxygen). Oxygen tension in
the blood was decreased in mice exposed to 15% oxygen (PO2 in the
blood was 37.8  5.8 mmHg in mice exposed to 21% oxygen and
24.2  2.4 mmHg in mice exposed to 15% oxygen, n = 4–5,
P = 0.073; Fig. 1). No differences were observed between blood
levels of CO2 (PCO2 in the blood was 33.7  6.2 mmHg in mice
exposed to 21% oxygen and 33.4  4.9 mmHg in mice exposed to
15% oxygen, n = 4 for each, P = 0.972; Fig. 1), and HCT did not
Fig. 1 The effect of systemic exposure to 15% oxygen on different parameters in blood and myocardial tissue. Bar graphs depicting PO2 (O2), PCO2
(CO2) and haematocrit (HCT) in the blood as well as ATP (ATP), lactate (Lactate), total NAD (NADt), NADH (NADH) and NAD+ (NAD+) in the
myocardial tissue. Each bar is a mean  S.E.M. (n = 3–5). *P < 0.05.
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differ between experimental groups (HCT was 39.0  3.0% in mice
exposed to 21% oxygen and 41.6  1.6% in mice exposed to 15%
oxygen, n = 5 for each, P = 0.434; Fig. 1). The level of ATP in heart
tissue was lower in mice exposed to 15% oxygen, but the difference
was not statistically significant (5.8  0.9 mmol/l in mice exposed to
21% oxygen and 3.7  1.2 mmol/l in mice exposed to 15% oxygen,
P = 0.200; n = 5 for each; Fig. 1). Lactate was also increased by
15% oxygen exposure, but, again, difference was not statistically sig-
nificant (0.16  0.02 mmol/l in mice exposed to 21% and
0.22  0.05 mmol/l in mice exposed 15% oxygen, P = 0.305, n = 5
for each; Fig. 1). Exposure to 15% oxygen did not significantly altered
total levels of NAD (23.9  0.1 nml/l for 21% oxygen and
24.0  0.2 nmol/l for 15% oxygen, P = 0.663, n = 3–4; Fig. 1), nor
levels of NADH (24.5  0.6 nmol/l for 21% oxygen and
20.7  1.8 nmol/l for 15% oxygen, P = 0.146, n = 3–4; Fig. 1) or
NAD+ (0.05  0.05 nmol/l for 21% oxygen and 3.3  1.7 nmol/l for
15% oxygen, P = 0.180; Fig. 1). Exposure to 15% oxygen signifi-
cantly increased level of SUR2A in mouse hearts (Fig. 2; signal inten-
sity was 34.4  8.1 AU (arbitrary unit) in mice exposed to 21%
oxygen and 198.1  12.0 AU in mice exposed to 15% oxygen,
n = 4–5, P < 0.001). On the other hand, the level of Kir6.2 was not
affected (Fig. 2; signal intensity was 89.7  11.5 AU in mice exposed
to 21% oxygen and 78.8  14.9 AU in mice exposed to 15% oxygen,
n = 3, P = 0.594).
24-hrs-long exposure to 15% oxygen does not
phosphorylate Akt or ERK1/2 in the heart
An increase in SUR2A is known to induce cardioprotection [5–10].
PI3K-Act is a cardioprotective signalling pathway, and from this per-
spective, it could regulate SUR2A expression. On the other hand, it
has been shown that chronic mild hypoxia activates in vitro ERK1/2
leading to increase in SUR2A levels in heart embryonic H9c2 cells
[21]. Therefore, in this study, we have tested whether phosphoryla-
tion of Akt and/or ERK is activated by exposure of mice to 15% oxy-
gen. Exposure to 15% oxygen was not associated with significant
phosphorylation of S473 Akt and T308 sites (S473 Akt: signal inten-
sity: 133.3  35.1 AU in mice exposed to 21% oxygen and
210.6  22.8 AU in mice exposed to 15% oxygen, n = 4–5,
P = 0.083; Fig. 3; the ratio phospho-S473 versus total Akt was
0.22  0.06 for mice exposed to 21% oxygen and 0.33  0.05 for
mice exposed to 15% oxygen, n = 4–5, P = 0.082; Fig. 3; T308 Akt:
signal intensity: 150.6  34.8 AU in mice exposed to 21% oxygen
and 181.8  20.7 AU in mice exposed to 15% oxygen, n = 4–5,
P = 0.427; Fig. 3; the ratio phospho-T308 versus total Akt was
0.25  0.05 for mice exposed to 21% oxygen and 0.28  0.04 for
mice exposed to 15% oxygen, n = 4–5, P = 0.585; Fig. 3). Exposure
to 15% oxygen did not have any effect on either ERK1 or ERK2 (signal
intensity: ERK1: 30.5  7.0 AU in mice exposed to 21% oxygen and
Fig. 2 The effect of systemic exposure to
15% oxygen on SUR2A and Kir6.2 levels
in myocardial tissue. Original Western
blots and corresponding graphs under
labelled conditions. Each bar is a
mean  S.E.M. (n = 3–5). *P < 0.05. AU:
arbitrary units.
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44.8  2.1 AU in mice exposed to 15% oxygen, n = 4–5, P = 0.382;
ERK2: 61.9  14.0 AU in mice exposed to 15% oxygen and
85.2  6.9 AU in mice exposed to 21% oxygen, n = 4–5, P = 0.156;
Fig. 4). The ratio phospho versus total ERK was also not affected for
both ERK1 (0.16  0.04 for mice exposed to 21% oxygen and
0.20  0.01 for mice exposed to 15% oxygen, n = 4–5, P = 0.602;
Fig. 4) and ERK2 (0.18  0.04 for mice exposed to 21% oxygen to
0.22  0.02 in mice exposed to 15% oxygen, n = 4–5, P = 0.344;
Fig. 4).
24-hrs-long exposure to 15% oxygen induces
AMPK phosphorylation
Activation of AMPK is known to stimulate trafficking of SUR2A
and KATP channels [25]. Therefore, we have examined whether
exposure to 15% oxygen induces AMPK phosphorylation. A low
but statistically significant increase in phosphorylated AMPK was
observed (signal intensity: 35.0  1.1 AU in mice exposed to
21% oxygen and 44.3  0.9 AU in mice exposed to 15% oxygen,
n = 4–5, P < 0.001; Fig. 5). The ratio phospho versus total AMPK
was also significantly increased after animals exposure to 15%
oxygen (ratio was 0.49  0.01 for mice exposed to 21% oxygen
and 0.56  0.01 for mice exposed to 15% oxygen, n = 4–5,
P = 0.002; Fig. 5).
AICAR increases the level of SUR2A in
embryonic heart H9c2 cells
AICAR is a well-established activator of AMPK [26]. Here, we have
exposed heart embryonic H9c2 cells to AICAR (1 mM) for 24 hrs. We
found that AICAR increased the level of SUR2A in these cells (Fig. 6;
signal intensity was 58.2  4.8 AU in control cells and 85.6  2.6
AU in AICAR-treated cells, n = 4–5, P = 0.001).
Discussion
Normobaric 15% oxygen corresponds to the oxygen tension at
~3000 m above sea level. In our previous studies, we have elucidated
the regulation of SUR2A by other oxygen tensions. Specifically, we
have examined the effect of 20% oxygen (350 m above sea level),
18% oxygen (1200 m above sea level) and 13% oxygen (3600 m
above sea level). In all three oxygen tension conditions, mice exhib-
ited increased SUR2A, but this occurred through distinct signalling
cascades. For 20% oxygen, it was via ERK1/2 while for 18% oxygen,
it was via PI3K/Akt [8, 22]. In contrast, for 13% oxygen (severe
hypoxia), no kinase was found to be phosphorylated and SUR2A
levels were increased due to changes in intracellular ATP levels [9].
In the present study, we have found that exposure to 15% oxygen
increased myocardial SUR2A levels in normal mice, but without
Fig. 3 The effect of systemic exposure to 15% oxygen on phosphorylation of Akt in the myocardium. Original Western blots with phospho-S473-
Akt, phospho-T308-Akt and total Akt antibodies applied on extracts from hearts under depicted conditions and corresponding graphs. Each bar is a
mean  S.E.M. (n = 4–5). *P < 0.05. AU: arbitrary units.
ª 2017 The Authors.
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activating ERK1/2 or PI3K/Akt signalling pathways. In mice exposed
to 15% oxygen, PO2 in the blood was significantly lower than in mice
at ambient oxygen, which is consistent with exposure to hypoxia [27].
On the other hand, ATP and lactate levels in the heart were decreased
and NAD+/NADH ratio increased. However, the difference was not sta-
tistically significant. It is generally accepted that hallmarks of myocar-
dial hypoxia are decreased ATP, changes in NAD+/NADH ratio and
increase in lactate [28]. It seems logically to expect that more pro-
nounced hypoxia would induce more pronounced decrease in ATP, an
increase in lactate and changes in NAD+/NADH ratio. However, our
findings are not in agreement with such notion. As an example, expo-
sure of mice to 18% oxygen induced significant increase in lactate that
was consequent to LDH up-regulation [8]. On the other hand, 13%
oxygen induced an unexpected increase in myocardial ATP levels due
to up-regulation of creatine kinase [9]. Thus, different oxygen tensions
are associated with different patterns of gene expression and regula-
tory networks, which influence intracellular levels of metabolites in dif-
ferent ways. This could explain our findings that 15% oxygen induced
less changes in intracellular lactate and NAD+/NADH than 18% oxy-
gen [8]. Also, 18% oxygen did not have any effect on intracellular ATP
Fig. 4 The effect of systemic exposure to 15% oxygen on phosphorylation of ERK1/2 in the myocardium. Original Western blots with phospho-
ERK1, phospho-ERK2 and total ERK1 and ERK2 antibodies applied on extracts from hearts under depicted conditions and corresponding graphs.
Each bar is a mean  S.E.M. (n = 4–5). *P < 0.05. AU: arbitrary units.
6 ª 2017 The Authors.
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levels [8], while 15% oxygen had the tendency to decrease ATP albeit
nonsignificantly. Accordingly, different metabolic response to different
oxygen tensions could account for activation different signalling path-
ways under such conditions. Despite these differences in general
response, 15% oxygen induced significant increase in SUR2A without
affecting Kir6.2, which is similar to results reported in subhypoxia
[19]. It has been shown that SUR2A regulates the level of sarcolem-
mal KATP channels in the heart and that the level of SUR2A dictates the
level of fully assembled channels [5]. Thus, an increase in SUR2A
results in increased number of sarcolemmal KATP channels, which, in
turn, is cytoprotective [29]. Such regulation of a single KATP channel
subunit is not surprising when known that regulation of both subunits
rarely happens [2, 6–9, 30, 31].
It has been suggested that high-altitude residents have lower mor-
tality rates for ischaemic heart disease [16–18] and animal experi-
mentation demonstrated that exposure to moderate hypoxia confers
Fig. 5 The effect of systemic exposure to 15% oxygen on phosphorylation of AMPK in the myocardium. Original Western blots with phospho-AMPK
and total AMPK antibodies applied on extracts from hearts under depicted conditions and corresponding graphs. Each bar is a mean  S.E.M.
(n = 4–5). AU: arbitrary units.
Fig. 6 The effect of AICAR on SUR2A
levels in H9c2 cells. Original Western
blots and corresponding graphs under
labelled conditions. Each bar is a
mean  S.E.M. (n = 4–5). *P < 0.05. AU:
arbitrary units.
ª 2017 The Authors.
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cardioprotection [19, 20]. The underlying mechanism is complex and
involves adaptive metabolic reorganization and metabolic gene
remodelling [28]. SUR2A has been recently shown to be a crucial reg-
ulator of myocardial resistance to different types of stresses, includ-
ing ischaemia-reperfusion [5–9]. An increase in SUR2A, irrespective
of what caused such increase, leads to increased myocardial resis-
tance to stress [5–10, 21–23, 29]. In addition, it has been suggested
that SUR2A controls cardiac ageing [10, 11]. More specifically, it has
been shown that ageing is associated with decrease in cardiac SUR2A
levels and that maintaining normal levels counteracts ageing-induced
increase in myocardial susceptibility to stress [10, 11]. Mice with non-
targeted expression of SUR2A are characterized by increased physical
endurance and slower decline in physical performance during ageing
[7, 10], and they seem to live significantly longer than wild-type mice
(our unpublished observation). Specifically, we have left four male
SUR2A mice (phenotype described in refs. [5–7]) until their natural
death. All mice lived considerable longer than expected and the short-
est lifespan in this cohort of mice was 1124 days and the longest was
1270 days (average lifespan was 1182  33 days, n = 4). Lifespan
of mice can vary considerably depending upon a particular strain.
Average lifespan of a male mice of a strain used to make SUR2A mice
is 735  17 days (n = 97, 23), which is significantly lower than
those for SUR2A mice; an increase in SUR2A expression seems to
increase lifespan for about 60%. SUR2A mice also lived significantly
longer (23.6% longer) than C57BLKS/J mice that have the longest
lifespan of usual mice laboratory strains (956  18 days, n = 100,
ref. [32]). Thus, increase in SUR2A could account for prolonged lifes-
pan reported in people living at high altitude [17]. Thus, manipulation
with SUR2A could be used as a therapeutic strategy against heart dis-
eases and for purpose of prolonging lifespan. However, it should be
pointed out that this is a preliminary study and more research on
experimental models with cardiovascular pathologies should be per-
formed before strong conclusions can be drawn.
Decrease in oxygen tension at various degrees is associated with
up-regulation of SUR2A, but different signalling cascades mediate up-
regulation of SUR2A at different oxygen tensions. About 20% oxygen
was shown to activate ERK1/2, 18% oxygen activated PI3K/Akt and
13% oxygen did not activate any of these kinases while all three oxy-
gen tensions did not activate AMPK [8, 9, 22]. Here, exposure of mice
to 15% oxygen did not affect ERK1/2 or PI3K/Akt, but it did activate
AMPK. It has been recently shown that change in intracellular AMP/
ATP is not required for activation of AMPK in hypoxia [33], which is
in agreement with our findings that 15% of oxygen was not associ-
ated with significant changes in intracellular ATP. AMPK is known to
mediate preconditioning-induced cardioprotection by stimulating traf-
ficking and activity of sarcolemmal KATP channels [25], but a link
between SUR2A and AMPK has never been previously established.
Therefore, to test whether activation of AMPK up-regulates SUR2A,
we have examined the effect of AICAR, a known AMPK activator on
SUR2A expression in the embryonic heart H9c2 cell line. We have
found that AICAR treatment increases the level of SUR2A in those
cells, hence showing that AMPK activity regulates expression of
SUR2A. Up-regulation of SUR2A by AMPK is in agreement with previ-
ous work suggesting that chronic activation of AMPK is associated
with cardioprotection [25]. It is well established that hypoxia-induci-
ble factor (HIF) is the master regulator of the transcriptional response
to hypoxia [34, 35]. However, we have previously shown that HIF
does not regulate SUR2A expression [21] and this is supported by
our findings that even small changes in oxygen that do not activate
HIF regulate SUR2A levels [22]. The relevance of SUR2A in chronic
adaptation to high altitude is yet to be fully established as we have
here tested only the response of mice to 24-hrs-exposure to 15%
oxygen. However, such relevance is likely as it has been shown that
mild hypoxia in vitro increases SUR2A mRNA within 24 hrs and that
longer stimulation of signalling pathways up-regulating SUR2A
results in sustained increase in SUR2A [6, 7]. Nevertheless, future
studies on regulation of SUR2A by chronichypoxia are required.
This study further adds to previous studies showing that different
oxygen tensions activate distinct signalling cascades [5, 6, 19]. How-
ever, irrespective of the cascade that is activated, the end result is
always increased levels of SUR2A. It seems that SUR2A plays a cen-
tral role in regulating myocardial resistance to hypoxia and oxidative
stress and up-regulation of this protein seems to be a compensatory
mechanism in decreased oxygen tensions and oxidative stress of dif-
ferent magnitudes.
In conclusion, this study brings for the first time preclinical proof
of the AMPK-mediated regulation of SUR2A activation due to 24-hrs
exposure to 15% oxygen.
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